<prompt> True about low molecular weight heparin except:Predictable bioavailabilityInhibit factor Ela and XaFavorable pharmacokineticsPT, apt monitoring not required.  <response>: Ans. B. Inhibit factor IIa and XaLow molecular weight is sensitive to factor Xa. It has better bioavailability. Its response is predictable therefore monitoring of PT is not required. Example are- dalteparin, enoxaparin. 